*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Within a few months, the Eurofins Group, active in the management of analytical, testing and technical inspection laboratories for private companies and public bodies, acquired sole control of the Bio-Access Group and later the Biomnis Group, two groups of laboratories specialising in medical biology. These two transactions were notified to the Competition Authority and authorised after a phase 1 without commitment. Reminder of contested decisions The acquisition of sole control, through the acquisition of a majority stake, of Bio-Access, a group active in the supply of so-called "routine" medical biological analyses, was approved by the Competition
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.